WID-Easy Endometrial Cancer Test Bundle
This care bundle utilises a groundbreaking diagnostic tool—the WID-Easy test—to provide a smarter, faster, and less invasive initial assessment for women with abnormal bleeding in perimenopause and menopause.
Traditional diagnostic pathways rely heavily on ultrasound, which can sometimes miss certain cancer types or lead to unnecessary biopsies due to false positives. The WID-easy test works differently. It doesn’t look for cancer cells themselves, but for unique “markers” on DNA (methylation patterns) that are present when cancer is in the womb lining. It correctly identifies approximately 96.5 out of every 100 women who truly have endometrial cancer and if your test result is negative, there is a greater than 99% certainty that you do not have endometrial cancer.
(This care bundle aligns with NCCN and UKGTN guidelines)
